Date/Time: Monday, October 22, 2018 - 3:30 PM to 5:30 PM
Type: Special Interest Group
Area: Movement Disorders
Room: Regency VI
Chair: Kathleen Poston, MD, MS – Stanford University Co-Chair: Alexander Y. Pantelyat, MD – Johns Hopkins University Describe the epidemiological evidence supporting the case for the involvement of obesity or related comorbidities in MS risk and prognosis. Describe the biological mechanisms, including metabolism, related to obesity and its comorbidities that may be detrimental to outcomes among people with MS. Describe the results of clinical trials that have focused on improving metabolism through diet, as well as some of the challenges of conducting such studies.
Characterize different movement disorders.
Describe what is known about the genetics associated with these disorders.
Describe what is known about the clinical and research implications of these new genetic discoveries.